Comment on chemotherapy resistance research
Breakthrough Breast Cancer comment on research from the Dana-Farber Cancer Institute in the USA and published online in Nature Medicine.
24 Jan
Email it
Your message will be:
Thought you might be interested in this page on Breakthrough Breast Cancer.
The researchers say they have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
Meg McArthur, from Breakthrough Breast Cancer, said:
"This research is a step towards discovering why some patients benefit more than others from a common form of chemotherapy. Research like this is important for identifying the appropriate treatment for individual patients.
"These are early, small-scale study results and more research is now needed before the benefits could be seen by patients."
